C4 Therapeutics, Inc.

Ownership Transactions Reported by 25 Insiders

Symbol
CCCC on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
490 Arsenal Way, Suite 120, Watertown, MA

There are no Buy or Sell transactions made by insiders since 12/22/2023

C4 Therapeutics, Inc. executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Alain J. Cohen Director $11.8M Apr 4, 2022
Glenn Dubin Director $6.58M Apr 1, 2024
Elena Prokupets Director $3.49M Sep 27, 2021
Kenneth Carl Anderson Director $1.78M Oct 1, 2024
Andrew Hirsch President & CEO, Director $1.55M Nov 7, 2024
Stewart Fisher Chief Scientific Officer $922K Sep 16, 2024
Kendra Adams Chief Financial Officer $573K Nov 7, 2024
Leonard Reyno Chief Medical Officer $459K Jul 10, 2024
Paige Mahaney Chief Scientific Officer $427K Oct 28, 2024
Scott N. Boyle Chief Business Officer $405K Nov 7, 2024
Jolie Siegel Chief Legal Officer $405K Nov 7, 2024
Kelly Schick Chief People Officer $405K Nov 7, 2024
Lauren White Chief Financial Officer $318K Aug 30, 2023
Adam Crystal Chief Medical Officer $250K Jan 30, 2023
Donna Roy Grogan Director $161K Oct 1, 2024
Mark Mossler Chief Accounting Officer $160K Feb 14, 2024
Bruce Downey Director Jun 20, 2024
Marc A. Cohen Director Jun 22, 2022
Stephen Fawell Director Aug 29, 2024
Utpal Koppikar Director Jun 20, 2024
Steven L. Hoerter Director Nov 19, 2024
Ronald Harold Wilfred Cooper Director Jun 7, 2024
Laura Bessen Director Jun 20, 2024
Malcolm Salter Director Jun 20, 2024
Owen Hughes Director Jun 20, 2024

Recent Insider Transactions by Companies or Individuals for C4 Therapeutics, Inc.

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.